Delivery Order SPE2DR25D2217-SPE2DR26FC7BY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pen injectors valued at $3,161.04 on November 24, 2025, with completion scheduled for November 25, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $111,508.90 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors on September 5, 2025, with completion expected by September 8, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract covers pharmaceutical supply for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,359.77 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on December 8, 2025, with completion expected by December 9, 2025. This firm fixed-price delivery order, with no set-aside designation, represents a competitively awarded transaction under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,843.94 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors (0.5 ml). This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by November 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply contract. The award represents a continuation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors with a ceiling value of $1,053.68. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The order is scheduled for completion by December 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,575.10 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injectors on November 6, 2025, with completion targeted for November 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pen injections valued at $7,983.73 on December 3, 2025, with completion expected by December 4, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's established relationship with DLA as a critical pharmaceutical distributor supporting federal medical procurement. The work will be performed at the vendor's...
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors with a completion date of August 19, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,082.99 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pen injectors on July 24, 2025. This firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, represents a routine pharmaceutical procurement for military healthcare needs. The contract was competitively awarded without set-aside designation and specifies performance at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,772.44 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors on November 20, 2025, with completion expected by November 21, 2025. This firm fixed-price delivery order, which received no set-aside designation, represents a routine pharmaceutical procurement fulfilling federal medical supply requirements. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This...
- SPE2DR25D2217Indefinite Delivery Contract
- SPE2DR25D2217-SPE2DR26FC7BYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,251.36 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors on December 3, 2025, with completion required by December 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's prime IDC with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. As one of the federal government's largest pharmaceutical distributors, AmerisourceBergen regularly fulfills delivery orders for specialty medications, vaccines, and medical devices across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 12/2/25 |